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Vero cells are considered as the most widely accepted continuous cell line by the regulatory authorities (such as 
WHO) for the manufacture of viral vaccines for human use. The continuous Vero cell line has been 
commercially used, after propagation on microcarriers, for the production of rabies, polio, enterovirus 71 and 
hantaan virus vaccines. Vero cell culture technologies are also explored for productions of many more viral 
vaccines over the last two decades. The growth of Vero cells is anchorage-dependent, and cells need to be 
dissociated enzymatically or mechanically for the process of subcultivation. This process is labor intensive and 
complicated in process scale-up. Adaptation of Vero cells to grow in suspension will simplify subcultivation and 
process scale-up significantly. 
 
Here we report on the adaptation of adherent Vero cells to grow in suspension using a serum-free and animal 
component-free medium developed in-house. The maximum cell density and cell doubling time of the 
suspension adapted Vero cells in batch culture grown in the in-house developed medium were similar to or 
better than what was observed for the adherent Vero cells grown in commercial media. The growth of 
suspension adapted Vero culture was successfully scaled up to 3 L bioreactor. The Vero cells from various 
stages (both adherent and adapted) were tested for their authenticity using a Short Tandem Repeat (STR) 
analysis.  The testing result indicates that all Vero cell samples have 100% concordance with the Vero DNA 
control sample, indicating the suspension adapted cells maintained their genetic stability. 
 
Productions of vesicular stomatitis virus (VSV) and influenza virus in adherent culture and suspension adapted 
culture were compared, showing the suspension adapted Vero cell retained similar viral productivity. The 
volumetric productivity of VSV in the suspension culture was even higher, and was further increased by almost 
200 times when culture was infected at higher cell density and with medium replacement before the virus 
infection. In contrast, the VSV production decreased when the adherent culture was infected at higher cell 
density. Additional process development revealed that the maximum cell density in batch culture was doubled, 
reaching 6x106 cells/mL, when the culture medium was replaced during the process of batch culture, which 
indicates potential for further increases in product titer. 
 
 
